Evidence map›Paper›PMID 42032340›Full record

ArticleImmunogenetics2026

Evolution of CCR1 and CCR1L1 reveals complex duplication scenarios in Muroids and Ruminants.

João Pedro Marques, Ana Pinheiro, Pedro José Esteves

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

João Pedro MarquesCIBIO-InBIO, Research Center in Biodiversity and Genetic Resources, University of Porto, Vairão, 4485-661, Portugal.
Ana PinheiroCIBIO-InBIO, Research Center in Biodiversity and Genetic Resources, University of Porto, Vairão, 4485-661, Portugal.
Pedro José EstevesCIBIO-InBIO, Research Center in Biodiversity and Genetic Resources, University of Porto, Vairão, 4485-661, Portugal. pjesteves@cibio.up.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokine receptor type 1 (CCR1) is expressed on several immune cells, including neutrophils, monocytes, and T cells. In rodents, a paralog of CCR1 was identified and called CCR1L1. Here, we studied the evolution of the CCR1 gene in mammals. Our results show that CCR1L1 is restricted to specific mammalian lineages, with muroids and ruminants each harbouring two CCR1-related paralogs. Topology tests do not unambiguously discriminate between independent duplications and an ancestral duplication followed by lineage-specific losses. Branch-site analyses revealed episodic positive selection acting on CCR1L1 lineages, including the basal branches of the two CCR1L1 clades. Moreover, we observed that selective regimes differ between the two CCR1L1 mammalian groups, with evidence for a shift in selection intensity in ruminants but not in muroids. We identified several amino acid changes in the structural components of chemokine receptors that are likely to impact the Ruminants CCR1L1 function. In Bos javanicus and Moschus berezovskii, CCR1L1 pseudogenes with premature stop codons were identified. Expression data indicate that Bos taurus, CCR1 is expressed in at least seven tissues, whereas CCR1L1 is only expressed in the lung. Together, these results suggest a complex evolutionary history for CCR1L1, involving duplication, lineage-specific selection, and, in some species, pseudogenization.

Indexed as

Evolution, MolecularGene DuplicationReceptors, CCR1RuminantsAmino Acid SequenceAnimalsCattleHumansMolecular Sequence DataPhylogenyPseudogenesSelection, GeneticReceptors, CCR1CCR1CCR1L1Gene duplicationMolecular evolution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.